We have previously described hTDE1, the human homologue of the recently described TDE1/TMS family of proteins whose members have been identified in several species. Although a defined biochemical activity has yet to be assigned to TDE1/TMS family members, previous results point to the overexpression of family members in tumor cell lines or tissues. To define whether hTDE1 may directly impact on neoplastic transformation, we derived and characterized stable Rat-1 transfectants that constitutively express hTDE1 at the plasma membrane. Expression of hTDE1 in Rat-1 transfectants had a significant effect on cell contact inhibition in vitro as judged by a focus formation assay. In addition, by monitoring caspase-3 activity and Hoechst staining, we determined that hTDE1 overexpression partially protects cells from serum starvation-and etoposide-induced apoptosis. Finally, hTDE1 Rat-1-expressing clones accelerated the formation of tumors in a nude mouse assay. Our results suggest that hTDE1 contributes directly to oncogenesis in vivo that may in part be explained by its effect on apoptosis in vitro.
Introduction
Transgenic mice carrying the polyomavirus large T antigen under the control of the metallothionein promoter develop tumors after long latencies, suggesting that secondary events contribute to oncogenesis in these mice (Chalifour et al., 1990 (Chalifour et al., , 1992 . Using this model system, we previously identified a novel gene, which we named TDE1 (for Tumor Differentially Expressed) following a screen of differentially expressed genes in cell lines derived from pre-or post-adematous testes of transgenic mice (Lebel and Mes-Masson, 1994) . This gene was also identified separately as TMS-1 (Grossman et al., 2000) and AIGP1 (Aoki et al., 2002) as well as Serinc3, described as a carrier protein that incorporates a polar-amino acid serine into cell membranes (Inuzuka et al., 2005) . In addition, we also cloned and characterized the human homologue of TDE1 (hTDE1) from a human placental cDNA library (Bossolasco et al., 1999) . The identification of additional family members gave rise to the notion of a larger TDE1/TMS family of proteins (Krueger et al., 1997; Grossman et al., 2000) , and members of this family have been identified in several species including Caenorhabditis elegans, Drosophila melanogaster, Fugu rubripes, Rattus norvegicus, Mus musculus and Homo sapiens. The members of this family share between 30 and 80% homology, contain multiple hydrophobic domains and often include an N-terminal signal peptide. In mouse, at least five homologues have been identified, scattered over four different chromosomes, whereas human TDE1/TMS genes have been found on five different chromosomes (The Wellcome Trust Sanger Institute, Ensemble). When comparing the sequence between human and mouse genes, it has been noted that most homologues between these two species locate on syntenic regions at the chromosome level suggesting evolutionary conservation (Table 1 ). The conserved nature of the gene structure and of the proteins sequence through evolution suggests an important biological role for TDE1/TMS family members.
Although membership to the TDE1/TMS family is expanding, there is still no evidence for a precise biochemical function for these proteins. Several groups have conducted studies related to select family members. Mouse TDE1 was originally described as being overexpressed in testicular tumors of transgenic mice and in cell lines derived thereof (Lebel and Mes-Masson, 1994) . Interestingly, Although tumor-derived transgenic cell lines generally overexpressed TDE1, this overexpression was more apparent in vivo in transgenic tissues. Similarly, we were able to detect high expression of hTDE1 in lung cancer tissue samples as compared to normal lung tissues, although again the degree of overexpression was more marked in tumor tissues versus cell lines (Bossolasco et al., 1999) . Overexpression of TMS-1/TDE1 was also noted in a small liver tumor (Grossman et al., 2000) . Whereas TMS-1/TDE1 is generally ubiquitously expressed (Lebel and MesMasson, 1994; Grossman et al., 2000) , a second mouse family member, TMS-2, appears to localize in the mouse brain, and is more specifically associated with areas with glutamatergic excitatory neurons such as the hippocampus and cerebral cortex (Grossman et al., 2000) . Although the protein location might suggest a role in vesicular glutamate transport, in vitro experiments aimed at demonstrating a glutamate uptake into cells expressing transfected TMS-2 were unsuccessful (Grossman et al., 2000) . It has been separately reported that TMS-1/TDE1 (AIGP1) expression is increased in mouse cortical neurons after in vivo axotomy (Aoki et al., 2002) . When in vitro-cultured mouse neurons were subjected to several endoplasmic reticulum (ER)-Golgi stress conditions, the same increase in AIGP1 expression was observed, suggesting that the protein might act as a sensor protein for ER-Golgi stress (Aoki et al., 2002) . Two new human members of the TDE1/TMS family have also been cloned. One of them, C5orf12 (Xu et al., 2003) , is the human homologue of the TPO1 rat gene (Krueger et al., 1997) . Based on its pattern of expression, it has been postulated that TPO1 is an essential component in the transition from proliferative prooligodendroblasts to postmitotic oligodendrocytes and that it plays a role in the rat myelin biogenesis (Krueger et al., 1997) and an analogous role in human brain has been suggested on the basis of sequence homology (Xu et al., 2003) . An additional human family member, TDE2, was identified by serial analysis of gene expression in non-small-cell lung cancers (NSCLC) (Player et al., 2003) . TDE2 was selected among several other differentially expressed genes because of its high level of differential expression when comparing lung tumors and primary lung epithelial cells. The authors performed in situ hybridization analysis as well as real-time quantitative PCR on lung tumors and nonmalignant lung tissues. In both experiments, TDE2 transcript expression was higher in NSCLC samples compared to expression levels in nonmalignant bronchiole epithelium. More recently, a biochemical function was suggested for several members of the family. Inuzuka and colleagues have been able to show that some members of TDE1/TMS family would act as carrier proteins, allowing incorporation of serine amino acid into membranes and thus facilitating the synthesis of phosphatidylserine and sphingolipids.
Given that overexpression of TDE1/TMS family members has been associated with oncogenic transformation in mice (Lebel and Mes-Masson, 1994; Grossman et al., 2000) and humans (Bossolasco et al., 1999; Player et al., 2003) , we were interested in directly accessing whether hTDE1 contributes directly to cell growth and transformation. Here we report on the stable expression of hTDE1 in a Rat-1 cell model and the characterization of transfectants by several in vitro and in vivo assays associated with oncogenic transformation. We further describe the construction, expression and effect on transformation of two N-terminal and one C-terminal deletion mutants of hTDE1.
Results
Expression and subcellular localization of hTDE1 and its mutants As previous attempts to generate a polyclonal antibody were unsuccessful, we generated a fusion protein, PGKhTDE1-GFP (PGK, phosphoglycerate kinase; GFP, green fluorescent protein) consisting of full-length hTDE1 fused in-frame just before the native stop codon Comparison of human and mouse family members. Percent identity was evaluated using the BLAST 2 SEQUENCES tool available on National Center for Biotechnology Information (NCBI, http://www.ncbi.nlm.nih.gov/blast/bl2seq/wblast2.cgi).
with sequences encoding GFP, in order to localize the protein at the cellular level. Two N-terminal (ND17hTDE1 and ND126hTDE1) and one C-terminal (CD112hTDE1) deletion mutants of hTDE1 were similarly constructed and fused with GFP. The putative structure of hTDE1, as defined by Ensemble (The Wellcome Trust Sanger Institute), as well as the location of deletion mutants, is detailed in Figure 1a . ND17hTDE1-GFP removes the first 17 amino acids of the protein, corresponding to the major portion of a putative signal peptide sequence. This mutation was generated in order to verify whether this signal peptide would be involved in translocation of the protein to the plasma membrane. ND126hTDE1-GFP lacks 126 amino acids corresponding to the first three transmembrane segments including the first 17 amino acids and thus eliminates the first two protein loops. In CD112hTDE1-GFP, the last 112 amino acids were removed, resulting in a fusion lacking the last two protein loops of hTDE1. Removal of this portion of the protein eliminates five of 12 previously identified putative phosphorylation sites (Bossolasco et al., 1999) . Protein expression was determined by Western blot analysis on transiently transfected Rat-1 cells, using the GFP antibody to detect fusion proteins. All constructs expressed a fusion protein of the expected molecular size (Figure 1b) .
To test biological function, stable clones were isolated from transfected Rat-1 cells expressing PGK-hTDE1, ND17hTDE1, ND126hTDE1 and CD112hTDE1. Northern blot analysis was used to confirm the expression of transfected sequences (Figure 1c ). Clones expressing high levels of full-length hTDE1 (PGKhTDE1-24 and PGK-hTDE1-34) or mutants of hTDE1, including clones expressing the ND17hTDE1 construct (ND17hTDE1-15 and ND17hTDE1-34), the ND126h TDE1 construct (ND126hTDE1-7 and ND126hTDE1-11) and the CD112hTDE1 construct (CD112hTDE1-6, CD112hTDE1-8 and CD112hTDE1-24), were selected for further analysis. A stable pooled population of HEK-293 cells expressing full-length hTDE1 was also generated (Figure 1d) .
To verify the subcellular localization of full-length and mutant hTDE1 protein, cells (Rat-1, HEK-293 and A-549 cells) were transiently transfected with appropriate constructs. Results in all cell types were comparable, and for clarity A-549 cells, which present a large cytoplasm, are presented (Figure 2 ). Whereas the pEGFP-N1 vector localized evenly in the nucleus and the cytoplasm (Figure 2a) , the full-length fusion protein PGK-hTDE1-GFP localized predominantly at the plasma membrane (Figure 2b ), although some signal was apparent at the perinuclear level. For the Following cDNA generation, expression was examined by semiquantitative PCR using b-actin and hTDE1 specific primers (see Materials and methods). 20 ml of the RT-PCR product was resolved on a 1% TBE agarose gel.
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ND17hTDE1-GFP fusion protein, although there was detectable signal at the plasma membrane, the majority of fluorescence appeared to concentrate in dot-like spots around the nucleus (Figure 2c ), suggesting that the loss of the signal peptide affects the translocation of hTDE1 to the plasma membrane. Similar fluorescent results were obtained with the ND126hTDE1-GFP fusion protein (data not shown). In contrast, the C-terminal mutant of hTDE1 was virtually indistinguishable from the full-length construct, with the majority of fluorescence localized to the plasma membrane ( Figure 2d ).
The effects of hTDE1 expression on various oncogenic parameters in vitro A focus formation test was performed in order to determine if hTDE1 expression affects the inhibitionof-contact associated with normal confluent Rat-1 cells ( Figure 3a ). Control and Rat-1 stable transfectants were left at confluence for 15 days. Full-length and C-terminal deletion hTDE1 transfectants ( Figure 3a ) demonstrated clear loss of contact inhibition with the formation of robust foci (>100 per plate), in contrast to N-terminal deletion mutants (Figure 3a ), which formed only sparse and minute foci (o10 per plate). Controls failed to produce significant number of foci (o2 per plate).
We measured the effect of hTDE1 on several parameters including cell proliferation, immortalization, motility and cell invasion. We did not detect any significant difference in the growth rate between clones expressing either the full-length or mutant forms of hTDE1 as compared to the parental Rat-1 cells (data not shown). Similarly, using a rat embryonic fibroblast assay, we were unable to demonstrate that full-length hTDE1 significantly impacted on cell immortalization (data not shown). Finally, we could not detect a biological effect associated with full-length hTDE1 using either a wound closure motility assay or in a Matrigelbased invasion assay (data not shown).
We next monitored the appearance of apoptotic cells using a Hoechst staining assay. A significantly greater number of cells with condensed nuclei were observed in Rat-1 cells as compared to hTDE1-expressing cells ( Figure 3b , left panel) at 24 h in both serum-starved and 40 mm etoposide treatment. Similarly, we tested caspase-3 activity, a major executor in the apoptotic signaling machinery, in cells grown in either complete media (control), medium with no FBS or in complete medium containing 40 mm etoposide. Rat-1 cells were compared to clones expressing full-length hTDE1 (PGK-hTDE1-24 and clone PGK-hTDE1-34), and caspase-3 activity was monitored by cleavage of a fluorescent substrate. Whereas a moderately lower of caspase-3 activity was observed in hTDE1-expressing clones at 24 h (data not shown), a clear statistical difference was noted both in serum-starved and etoposide conditions between Rat-1 cells and hTDE1-expressing clones ( Figure 3b , right panel) at 48 h. Internucleosomal DNA fragmentation, a hallmark of apoptosis, was visualized by agarose gel electrophoresis. After etoposide treatment, control Rat-1 and HEK-293 cells as well as clones PGK-hTDE1-24 and PGKhTDE1-34 or HEK-293 cells expressing hTDE1 displayed the typical DNA ladder associated with cells undergoing apoptosis (Figure 4a ). Hypodiploid DNA, characteristic of cells in an advanced stage of apoptosis, was also measured by detecting the presence of a sub-G1 peak following flow cytometry analysis. The percentage of cells with hypodiploid DNA was higher in both Rat-1 and HEK-293 control The effects of hTDE1 expression in vivo: nude mice xenograft assay To determine the effect of hTDE1 expression on in vivo tumorigenesis, we injected either Rat-1 cells or clones expressing either full-length hTDE1 (PGK-hTDE1-24 and PGK-hTDE1-34) or the hTDE1-GFP fusion (PGKhTDE1-GFP-16) subcutaneously in nude mice and monitored tumor formation ( Figure 5 ). Rat-1 cells, as well as controls transfected with empty vector, either failed to form tumors or presented with small masses. In contrast, PGK-hTDE1-34 rapidly formed large tumors and the majority of mice had to be killed at B50 days. Clones PGK-hTDE1-24 and PGK-hTDE1-GFP-16 also produced robust tumor formation, although with a longer latency.
Discussion
The TDE1/TMS family includes several members, and different homologues have been identified in several species. Table 1 summarizes available data for the mouse and human family members. Although a definitive biochemical function has yet to be defined for the family members, as a group they have been classified as transmembrane proteins. Cellular location and protein function are closely related. Indeed, aberrant subcellular localization of proteins is observed in cells of various diseases, such as in cancer, supporting the idea that cellular protein localization provides key information essential to assign functions to known (Ferrigno and Silver, 1999; Faust and Montenarh, 2000; Pearce, 2000) and novel proteins (Simpson et al., 2000) . Previous reports on mouse TMS-1, TMS-2 (Grossman et al., 2000) and AIGP1 (Aoki et al., 2002) have addressed their subcellular localization. Surprisingly, despite being homologues, these proteins were Hoechst staining experiments were repeated 3-4 times, and in each, 11-16 independent fields were analysed. Caspase-3 activity was measured as pmol/mg min and experiments were repeated twice in duplicate. For both caspase-3 and Hoechst experiments, white columns represent Rat-1 cells, stripped columns represent PGK-hTDE1-24-expressing cells and squared columns represent PGK-hTDE1-34-expressing cells.
Oncogenic properties of hTDE1 M Bossolasco et al localized to different compartments. Based on results obtained from an HA C-terminal epitope-tagged construct of TMS-1, transiently transfected into HEK 293 cells, it was determined that this protein localizes to the plasma membrane (Grossman et al., 2000) . In contrast, AIGP1 was predominantly localized to the Golgi complex based on immunofluorescence staining of cultured cortical neurons using a AIGPI-specific antibody (Aoki et al., 2002) . Data from Inuzuka et al. (2005) suggest a co-localization of Serinc proteins with lipid biosynthetic enzymes in endoplasmic reticulum membranes. In the present report we have addressed the localization of hTDE1, the human homologue of this family. Our results, based on a GFP C-terminal fusion, clearly demonstrate the protein localized to the plasma membrane of the cell. In addition, it is also possible to visualize highly fluorescent dot-like structures in the perinuclear area of the cell. This latter fluorescence may be explained by hTDE1 overexpression resulting in large amounts of protein that may accumulate transiently during protein maturation. This accumulation may also generate improperly folded proteins and subsequently interfere with the ultimate membrane localization of the protein (Stevens and Argon, 1999) . Alternatively, a large number of transmembrane proteins, including receptors, channels and transporters, are known to cycle and in some cases this includes the presence of a retention apparatus allowing membrane proteins to be stocked in vesicles outside the constitutive exocytotic pathway (Royle and Murrell-Lagnado, 2003) . We also demonstrate that the N-terminal mutant of hTDE1, lacking the putative signal peptide, displays increased perinuclear signal with a concomitant loss in plasma membrane fluorescence. An accumulation in the RERGolgi complex is characteristic of proteins in which N-terminal sequences involved in the translocation of Oncogenic properties of hTDE1 M Bossolasco et al protein to the plasma membrane are missing (Stevens and Argon, 1999) supporting an important role of N-terminal sequences in the final destination of mature protein. In contrast, the hTDE1 C-terminal mutant, similar to the full-length protein, translocates to the plasma membrane, suggesting that these sequences are dispensable to proper protein subcellular localization. Previous reports, including ours, suggest that aberrant expression of TDE1/TMS family members may be involved in the process of cellular transformation (Lebel and Mes-Masson, 1994; Bossolasco et al., 1999; Grossman et al., 2000; Player et al., 2003) . In this report, we have directly assessed the transforming properties of hTDE1 following stable transfection in the Rat-1 cell line. Comparing parental and hTDE-1 Rat-1 cells, we analysed both in vitro and in vivo characteristics associated with oncogenic cell transformation. Although hTDE1 expression appeared to have little effect on assays that measure cellular migration, invasion, immortalization and proliferation, we did observe a clear effect of hTDE1 expression on assays measuring response to apoptotic stimuli, contact inhibition and tumor formation in nude mice.
The fact that hTDE1 affects some, but not all, of the parameters associated with cell transformation is perhaps not surprising as this phenomenon has been observed for a number of viral and cellular oncogenes (Renan, 1993) . Our experimental approach, the in vitro wound closure assay (Ronot et al., 2000; Shigeta et al., 2003) , might reflect either a change in cell migration or a modification in intracellular adhesiveness. When comparing Rat-1 cell wound closure with clone PGKhTDE1-24 and PGK-hTDE1-34, we failed to detect any significant impact, suggesting that hTDE1 is not involved in cell motility or cell-to-cell adhesion. The Matrigel matrix used to assess cellular invasiveness again provided no differences between Rat-1 cells and clones PGK-hTDE1-24 and PGK-hTDE1-34. In order to address the effect of hTDE1 on senescence, the in vitro immortalizing activity of hTDE1 was compared to that of Py-LT, a protein known to exhibit immortalizing properties (Rassoulzadegan et al., 1983) . Results were not conclusive and therefore could not attribute an immortalizing function for hTDE1. Although cancer cells generally are thought to cycle more rapidly, all tumor cells do not necessarily proliferate faster than normal cells (Cancer Medicine, 6th edn. BC Decker Inc., 2003). Compared to the Rat-1 parental cell lines, expression of either the full-length hTDE1, or N-and C-terminal deletion mutants of hTDE1, had no appreciable effect on proliferation rates.
It has been suggested that the unrestrained increases in the number of tumor cells is not only owing to an increase in cellular proliferation because of an accelerated or uncontrolled cell cycle, but also may more closely be linked to an imbalance between the number of dividing cells and the number of cells progressing to terminal differentiation or death (Corn and El-Deiry, 2002; Green and Evan, 2002; Nowell, 2002) . Indeed, we assessed hTDE1 ability to impact on apoptosis, both in response to serum starvation and etoposide exposure. In both cases, the number of hTDE1-expressing cells undergoing apoptosis were significantly reduced compared to the parental Rat-1 cells, and this was accompanied by a significant decrease in caspase-3 activation in the hTDE1-expressing clones. Cellular death was also measured by sub-G1 peak detection through flow cytometry, and apoptosis was confirmed through visualization of a characteristic DNA ladder on agarose gel. Results obtained from Rat-1 cells were comparable to those we observed in HEK-293 cells, suggesting that hTDE1 impact on apoptosis was not dependent on the cell type used for the analysis. These results are in stark contrast to those associated with the effect of AIGP1 on apoptosis, where this TDE homologue was found to promote apoptosis in axotomized mice neurons (Aoki et al., 2002) . In addition, induction of apoptosis was also observed following transient transfection of COS 7 cells with AIGP1 (Aoki et al., 2002) . Differences between the effect of AIGP1 and hTDE1 may be explained by differences at the protein level (the proteins share 77% homology) or differences in the model systems used to test apoptosis, including the observation that AIGP1 induces apoptosis following transfection whereas in this report stable clones were tested for their ability to resist specific inducers of apoptosis. Differences related to protein sequence and function are supported by the observation that the apoptotic rate was unchanged following transfection of COS-7 cells with TPO1, a rat TDE1/TMS family member (Aoki et al., 2002) . Alternatively, the level of expression of the transfected protein may play a role in the final outcome although this is difficult to evaluate, because in the case of AIGP1 expression was driven in mouse and COS-7 cells using a CMV-based promoter, whereas hTDE1 was under the control of the PGK promoter in Rat-1 and HEK-293 cells. Finally, a fundamental difference was also noted in subcellular localization of these family members, with AIGP1 localized at the Golgi and hTDE1 at the plasma membrane, which may in part account for the different Loss of density-dependent inhibition and contact inhibition results in the formation of disordered, multilayer array of cells that are observed as foci growing on a cellular monolayer (Temin and Rubin, 1958) . It is noteworthy that whereas both full-length and C-terminal mutants of hTDE1 were able to form foci, N-terminal mutants, which fail to locate to the plasma membrane, rarely formed foci. Several membrane molecules that are part of adhesion junctions, including cadherins, are thought to play a role in densitydependent contact inhibition (Grazia Lampugnani et al., 2003; Bazzoni and Dejana, 2004) and the presence of hTDE1 may similarly impact on adhesion when present at the plasma membrane. C-terminal mutant clones were also able to form foci, and these were generally more compact than those observed with fulllength hTDE1, and coupled to the observation that these mutants are less able to migrate through a Matrigel matrix, hint at the possibility that hTDE1 affects cell adhesion. How and whether hTDE1 proteins are involved in cell-to-cell adhesion and migration is unclear and warrants further investigation.
The ultimate characteristic of the oncogenic cell is its ability to form tumors in an in vivo environment. Therefore, the most striking observation in this report is the ability of PGK-hTDE1-34 and PGKhTDE1-24 cells to form tumors in a nude mouse xenograft assay. Control mice either failed to develop tumors or developed minute masses at the site of injection. Mice injected with clone PGK-hTDE1-24 and clone PGK-hTDE1-GFP-16 cells were also shown to be able to consistently form tumors, although the latency was somewhat longer. This result also further demonstrates that the addition of the GFP moiety at the C-terminal end of the protein does not impact on its tumorigenic potential, and further supports that the ultimate cellular localization of the protein is at the plasma membrane.
In conclusion, although we have as yet to assign a precise function to TDE1/TMS family members, the results presented here, coupled to our previous results in tumor-bearing transgenic mice and the demonstration that hTDE1 overexpression can be observed in tumor tissues (Bossolasco et al., 1999) , strongly support a role for hTDE1 in the oncogenic process. However, the ultimate role of hTDE1 in human cell transformation, and specifically, its possible role in human carcinogenesis, needs to be further investigated. The present study also underlies the ability of hTDE1 to interfere with programmed cell death, allowing cells to escape control mechanisms established in multicellular organisms to eliminate malfunctioning cells such as transformed cells. The identification of cellular proteins able to interact with TDE1/TMS family members would no doubt contribute to a better understanding of hTDE1 function and allow us to better understand how these proteins impact on transformation.
Materials and methods

Plasmid constructs
The hTDE1 full-length sequence was amplified from a placental cDNA library plasmid (Bossolasco et al., 1999) using the 5 0 sense primer 5 0 -CACGAGCTCAGCTGGCAGT TA-3 0 and the 3 0 antisense primer 5 0 -CCGGATCCCACCT GAACTCCCGAC-3 0 , thus eliminating the hTDE1 stop codon. The 1495 bp PCR product and the pEGFP-NI vector (Clontech, Palo Alto, CA, USA) were digested with SacI and BamHI and ligated to generate the intermediate cloning vector hTDE1-GFP. The hTDE1 sequences were extracted from hTDE1-GFP using XhoI/BamHI and re-cloned within the XhoI/BamHI site of a PGK-GFP-hygro vector (Rodier et al., submitted) giving rise to PGK-hTDE1-GFP where hTDE1 is fused in-frame at its C-terminus with GFP. PGK-hTDE1-GFP is selectable in hygromycin and the hTDE1-GFP sequence is under the control of the PGK promoter. PGK-GFP-hygro was also digested with BsrG1 within GFP sequences, blunt-ended with Klenow fragment and digested with SacI. This product was ligated to the SacI/SspI hTDE1 fragment (Bossolasco et al., 1999) giving rise to PGK-hTDE1, which directs the expression of full-length protein not fused to GFP sequences.
N-and C-terminal deletions mutants were generated. Following intermediate steps that allowed the introduction of 5 0 cloning sites associated with a start codon, ND17hTDE1-GFP was generated. This plasmid is similar to PGK-hTDE1-GFP except for the deletion of the first 17 amino acids of hTDE1. A similar strategy was used to clone ND126hTDE1-GFP where the first 126 amino acids of hTDE1 were deleted. Introduction of stop codon between TDE1-GFP sequences also allowed the generation of ND17hTDE1 and ND126h TDE1 in which hTDE1 N-terminal mutants are expressed without fusion to GFP. Following intermediate steps that allowed the removal of the last 112 amino acids of hTDE1, the plasmid CD112hTDE1-GFP was generated in the XhoI/ BamHI backbone of the PGK-GFP-hygro vector that allows the expression of a fused C-terminal deletion mutant of hTDE1 with GFP. Introduction of a stop codon between the hTDE1 and GFP sequences allowed the generation of CD112hTDE1 in which the C-terminal deletion of hTDE1 is expressed without associated GFP sequences.
For cloning experiments, restriction and modifying enzymes were purchased from New England Biolabs (NEB, Beverly, MA, USA) and final constructs were sequence verified.
Cell culture and transfection All cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Wisent, Quebec, Canada) supplemented with 10% fetal bovine serum (FBS; Wisent), 50 mg/ml gentamycin (Invitrogen, Carlsbad, CA, USA) and 2.5 mg/ml amphotericin B (Wisent). Cells were maintained at 37 o C under an atmosphere of 5% CO 2 . For transfection experiments, Rat-1, HEK-293 and A-549 cells were transfected using Lipofectamine (Invitrogen). Cells were grown in 100 mm dishes and transfected at 80% confluence with 10 mg of plasmid, 20 ml of lipofectamine and 30 ml of ReagentPlus, according to the manufacturer's protocol. For Rat-1 stable transfections, cells were passed at a 1:3 dilution 24 h after transfection and maintained in medium containing 75 mg/ml hygromycin B (Roche Applied Science, Basel, Switzerland). For HEK-293 stable transfections, cells were maintained in medium containing 75 mg/ml hygromycin B (Roche Applied Science, Basel, Switzerland) for several months resulting in a mixed population of cells expressing hTDE1.
Western blot analysis
Cells were scraped, resuspended in lysis buffer (50 mM TrisHCl pH 6.8, 100 mM dithiothreitol (DTT), 10% glycerol) and sonicated for 30 s (Scientific Instruments, KS212 model, Ringoes, NJ, USA). Sonication was followed by 10 min centrifugation at 13 000 r.p.m. at 41C. The supernatant containing the proteins was transferred to another tube and protein concentration was determined with the Bradford method. From 20 to 50 mg of proteins were loaded on a 9% SDS-polyacrylamide gel electrophoresis acrylamide gel. After migration, proteins were subsequently electrotransferred on a nitrocellulose membrane for 1 h at 41C at 200 mA (Bio-Rad Trans-Blot Cell, Hercules, CA, USA). For protein detection, membranes were blocked overnight with 5% skin milk and 0.1% Tween 20. Primary antibodies for GFP Clontech) or b-actin (AC-14, Abcam, Cambridge, UK) detection were diluted 1:8000 and 1:10 000, respectively, in 5% skin milk and 0.1% Tween 20 buffer. Membranes were incubated for 45 min with the b-actin primary antibody or for 3 h with the GFP primary antibody and were subsequently washed with phosphate-buffered saline (PBS) containing 2% Tween 20. Secondary antibody consisting of anti-mouse IgG-HPR conjugated (Santa Cruz Antibodies, Santa Cruz, CA, USA) was used at a 1:12 000 dilution rate. The ECL (Amersham Biosciences, Buckinghamshire, UK) kit was used to detect the signal on the membranes.
RNA purification, Northern blots analysis and reverse transcription-PCR. RNA was isolated with TRIsol reagent (Gibco/BRL, Life Technologies Inc., Grand Island, NY, USA). Purified RNA was quantified spectrophotometrically, and the quality was determined by ethidium bromide staining after agarose electrophoresis. For each sample, 20 mg of total RNA was electrophoresed through a 1% agarose gel containing 0.36 M formaldehyde. Transfer was performed on a GeneScreen Plus hybridization transfer membrane (NEN Life Science Products, Boston, MA, USA). The gel was washed two times in 0.05 M NaOH in 1 Â SSC for two 10 min periods, then soaked in 10 Â SSC for two 20 min periods in 10 Â SSC. Capillary transfer was performed overnight in 10 Â SSC. The membrane was UV-crosslinked (UV-Stratalinker 2400, Stratagene, Cedar Creek, TX, USA) and hybridized overnight at 641C, in 1% SDS, 1 M NaCl and 10% dextran sulfate supplemented with 100 mg/ml of salmon sperm DNA and labeled probe. All probes were labeled overnight at room temperature using a random primer labeling system (Redprimet II, Amersham Biosciences, Buckinghamshire, UK). A probe corresponding to the mouse b-actin RNA was used as internal control. After overnight hybridization, membranes were rinsed twice for 30 min with 2 Â SSC and 0.1% SDS. Membranes were exposed to Kodak BioMax MS films with an intensifying screen at À801C overnight.
Five micrograms of total RNA was converted to singlestranded cDNA by using murine reverse transcriptase in a volume of 30 ml containing 6 ml of 5Â first strand buffer (250 mM Tris-HCl (pH 8.3), 375 mM KCl, 15 mM MgCl 2 ), 10 mM DTT, 0.6 mM dNTPs, 33 U of RNase guard, 0.5 mg of oligo-dT primers and 400 U of M-MLV Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA). The reaction was performed at 421C for 60 min. For the subsequent PCR, reaction, 5 ml of the cDNA reaction product was amplified by using 5 0 -GGGGCTGTGCTGGGTGTCTT-3 0 for the 5 0 sense primer and 5 0 -CGGATCCGTGTCCTTGGCACTCAGAGGT -3 0 for the 3 0 antisense primer. Amplification of the b-actin as a positive control was performed using 5 0 -CATCGAG CACGGCATCGTCA-3 0 for the 5 0 sense primer and 5 0 -TAGCACAGCCTGGATAGCAAC-3 0 for the 3 0 antisense primer. PCR reaction was performed in a final 50 ml containing 5 ml of 10 Â PCR buffer, 2 mM MgCl 2 , 200 mM dNTPs, 0.2 mM of sense and antisense primers and 2 U of FastStart Taq DNA Polymerase (Roche, Applied Science, Basel, Switzerland). PCR was performed for 25 cycles at 941C for 30 s, 581C for 30 s and 721C for 1 min.
Foci formation assay Cells were seeded in 100 mm Petri dishes (SARSTEDT, Nu¨mbrecht, Germany) grown to confluence and re-fed with fresh media twice a week. Confluence was maintained for 15 days, following which cells were washed with PBS, rinsed in 50% methanol/50% PBS and subsequently incubated for 10 min in fresh anhydrous methanol. Cells were stained with Giemsa Stain Stock Solution (VWR Scientific Products, West Chester, PA, USA), diluted 1:5 in deionized water and incubated overnight. In the morning, dye was removed and Petri dishes were rinsed with deionized water, dried, photographed and focus formation was scored.
Hoechst staining 3 Â 10 4 cells were seeded on microscope coverslip glass (no. 12, Fisherbrand, Fisher Scientific, Leicestershire, UK) in 24-well plates (Falcon, Becton Dickinson, Palo Alto, CA, USA). Cells were allowed to settle for 24 h. Apoptosis was then induced by replacing medium with either serum-free media or by media supplemented with 40 mm etoposide (Sigma-Aldrich, St Louis, MO, USA). Following 24 and 48 h treatments, 1 ml of a 10 mg/ ml Hoechst stain solution (Bisbenzimide H33258, SigmaAldrich, St Louis, MO, USA) was added to each well. Cells were incubated at 371C for 1 h. Microscope coverslips were then removed and placed on a microscope slide (Corning glass Works, Corning, NY, USA). Five fields per coverslip were examined under a fluorescent microscope (excitation wavelength 365 nm, emission wavelength 465 nm, 40 Â 0.60 magnification, NIKON eclipse TE300, Tokyo, Japan) and apoptotic and living cells were counted.
Caspase-3 activation assay Caspase-3 activity was measured using the Ac-DEVD-AFC substrate and assayed according to the manufacturer's protocol. Briefly, cells were seeded at 70% confluence. After 24 h, apoptosis was induced by replacing media with either serum-free media, or complete media supplemented with 40 mm etoposide. Both adherent and floating cells were harvested at 24 and 48 h post-treatment, placed in a 15 ml tube and cells were pelleted at 1500 r.p.m. for 10 min. Pellets were resuspended in cold PBS, transferred to Eppendorf tubes and re-pelletted at 1500 r.p.m. for 10 min. Supernatants were discarded, and pellets were suspended in 70 ml of lysis buffer (Invitrogen, Carlsbad, CA, USA). Cells were placed on ice for 10 min, debris was pelletted and supernatants were stored at À801C. Protein concentration was measured at 579 nm by the BCA protein quantification kit (Pierce, Rockford, IL, USA). For each assay, 35-50 mg of protein was incubated for 30 min with 50 mM Ac-DEVD-AFC at 301C. Fluorescence was analysed using a FluoStar-Optima microplate reader (BMG lab Technologies, Offenburg, Germany) in fluorescence mode using an excitation filter of 380 nm (10 nm bandpass) and an emission filter of 505 nm (10 nm bandpass). The reaction was allowed to proceed for 30 min with a reading every minute. Caspase-3 activities were obtained by calculating the slope of the reaction over 30 min for each assay.
DNA ladder assay
Cells were seeded at 70% confluence. After 24 h, apoptosis was induced by replacing media with complete media supplemented with etoposide. A final concentration of 40 mM etoposide was used on Rat-1 control and transfected cells, whereas a 10 mM etoposide final concentration was used on HEK-293 control and transfected cells. Both adherent and floating cells were harvested at 24 and 48 h post-treatment, placed in a 15 ml tube and pelletted at 1500 r.p.m. for 15 min. Pellets were resuspended in 1 ml final volume of 1 M Tris-HCl pH 8, 0.5 M EDTA pH 8 and 10% SDS containing 100 mg/ml of Proteinase K (Fermentas, Burlington, Canada) and samples were incubated at 371C with shaking overnight. The day after, samples were chilled on ice for 10 min. A 400 ml volume of 5 M NaCl was added and tubes were inverted several times to mix. Samples were spun for 15 min at 3400 r.p.m. The supernatant was transferred to a new tube and DNA was precipitated by adding 2 volumes of 100% ethanol. The pellet was resuspended in 20 ml of water and incubated at 371C for 30 min with RNase A (usb, Cleveland, OH USA) at a final concentration of 20 mg/ml. Electrophoresis was performed in 1.6% agarose gel in TBE buffer, after which DNA was visualized by ethidium bromide staining. DNA fragmentation analysis was assessed by resolving 10-20 mg of DNA for each sample.
Determination of hypodiploid DNA content
To measure the loss of DNA owing to cell death, cells were seeded at 70% confluence. After 24 h, apoptosis was induced by replacing media with complete media supplemented with etoposide. A final concentration of 40 mM etoposide was used on Rat-1 control and transfected cells, whereas a 10 mM etoposide final concentration was used on HEK-293 control and transfected cells. Both adherent and floating cells were harvested at 24 and 48 h post-treatment, placed in a 15 ml tube and pelletted at 1500 r.p.m. for 15 min. Cells were fixed by resuspending pellets in ice-cold 70% ethanol for 1 h. One hour before performing flow cytometry analysis, ethanol-fixed cells were washed twice with PBS. Cells were then resuspended in PBS containing 0.5 mg/ml RNase A (usb, Cleveland, OH, USA) and 40 mg/ml propidium iodide (Molecular Probes, Invitrogen, Carlsbad, CA, USA) and incubated at room temperature for 30 min. Samples were analysed using a Becton Dickinson Fac Scan Flow Cytometer (Becton Dickinson, CA, USA) as described by Ormerod et al. (1992) . Cells with sub-G1 (hypodiploid DNA) propidium iodide incorporation were considered apoptotic.
Tumorigenesis assay
Four-to seven-weeks-old CD1 Br Nu/Nu mice (Charles Rivers, St-Constant, Qc) were used for tumor growth xenografts experiment. Stable clones expressing PGK-GFP (empty vector), PGK-hTDE1-GFP and PGK-hTDE1 were tested. Rat-1 (non-transfected) cells and PBS alone were also used as negative controls. Mouse flanks were injected subcutaneously with 2.5 Â 10 6 cells for each clone (six mice per clone) and tumor size was measured every 2 weeks for 4 months. Mice were killed early when tumor volumes reached >2 cm 3 .
Statistical analysis
All statistical analyses were performed using the InStat3 GraphPad Software (GraphPad Software Inc. (c) 1990 -2001 .
